AnaptysBio, Inc. (ANAB)
NASDAQ·Healthcare·Biotechnology
$56.12
+3.47%
Mkt Cap $2.25B
Analyst Ratings
Buy
15
Hold
1
Sell
0
Price Target (28 analysts)
$73.88
Range $50.00 – $140.00
Implied Upside
+31.6%
Consensus $73.88 vs current $56.12
NASDAQ·Healthcare·Biotechnology
$56.12
+3.47%
Mkt Cap $2.25B
Buy
15
Hold
1
Sell
0
Price Target (28 analysts)
$73.88
Range $50.00 – $140.00
+31.6%
Consensus $73.88 vs current $56.12